USFDA Approves Corcept Therapeutics’ Ovarian Cancer Drug Lifyorli
Bengaluru: Corcept Therapeutics shares jumped more than 23% to a near two-month high on Wednesday after the U.S. health regulator approved the company's lead drug for treating an aggressive form…